Source comparison
Direct Answer: Mechanism vs Dosage
Most resources frame Hexarelin strictly as a growth hormone secretagogue. Which it is. But that framing misses the cardiac mechanism entirely. The cardioprotective effects operate through CD36 receptor binding in cardiomyocytes, triggering intracellular signal
This comparison does not assign a generated winner or score.
- Most resources frame Hexarelin strictly as a growth hormone secretagogue. Which it is. But that framing misses the cardiac mechanism entirely. The cardioprotective effects operate through CD36 receptor binding in cardiomyocytes, triggering intracellular signaling cascades that reduce oxidative stress and inhibit apoptosis during ischemic events. This pathway is GH-independent.
- This article covers the specific dosing protocols emerging from 2023–2026 cardiac research, the mechanistic distinction between GH-driven and cardioprotective pathways, what preparation and administration variables matter for cardiac outcomes, and what the clinical translation timeline looks like based on current Phase II data.